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Resiniferatoxin (RTX) is an ultrapotent synthetic TRPV1 (transient receptor potential vanilloid sub-
type 1) agonist with signiﬁcant initial transient hyperalgesia followed by a prolonged analgesic eﬀect in 
response to thermal stimulus.  Using a rat model of neuropathic pain,  we evaluated the eﬀect of pre-
treatment with clonidine－which has been shown to relieve intradermal capsaicin-induced hyperalgesia
－on the initial hyperalgesic response and the thermal analgesic property of RTX.  Thirty-six male rats 
were divided into 6 treatment groups (n＝6 each): RTX 500ng,  RTX 1µg,  clonidine 20µg (Cl),  Cl＋
RTX 500ng,  Cl＋RTX 1µg,  or normal saline 20µL (control).  We evaluated the short-term (180min) 
and long-term (20 days) analgesic eﬀects of RTX after thermal stimulation and mechanical stimulation.  
RTX had signiﬁcant initial transient hyperalgesia followed by a prolonged analgesic eﬀect in response 
to the thermal stimulus,  but the RTX 500ng and RTX 1µg groups showed no initial short-term thermal 
hyperalgesic responses when pretreated with clonidine.  The Cl＋RTX 1µg ratsʼ behavior scores indi-
cated that they were more calm and comfortable compared to the RTX 1µg rats.  Even though we 
cannot precisely conﬁrm that pretreatment with clonidine potentiates or adds to the analgesic eﬀect of 
RTX,  clonidine pretreatment with epidural RTX eliminated the initial RTX-associated hyperalgesic 
response and systemic toxicity in this neuropathic pain rat model.
Key words: clonidine,  epidural administration,  resiniferatoxin,  spinal nerve ligation rat model,  thermal 
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he chemical resiniferatoxin (RTX),  which induces 
the long-term desensitization of nociception,  
provides conduction analgesia via selective blocking of 
transient receptor potential vanilloid subtype 1 
(TRPV1),  which is expressed by A-δ and C-ﬁber 
sensory neurons [1-3].  However,  the use of RTX is 
controversial because its neurotoxicity and margin of 
safety have not been addressed adequately [4].  Upon 
an initial encounter with nociceptive ﬁbers in rats,  
RTX induced a robust hyperalgesia response due to its 
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ultrapotent capsaicin-like property [1].  Although this 
hyperalgesic response was transient,  it appears to 
have a signiﬁcant impact on the safety and eﬃcacy of 
the RTX use [4].
　 In a previous study with rats,  we observed pro-
longed thermal analgesia with 1-µg RTX without 
respiratory paralysis or sedation [5].  However,  all of 
the RTX-treated rats showed distinct acute systemic 
toxicity (e.g.,  irritation and somnolence) and a tran-
sient thermal hyperalgesic response to the initial 
administration of RTX [5].  The initial pain response 
has been a deterrent to widespread use of RTX [4].
　 In other studies,  pretreatment with 0.5ｵ bupiva-
caine prior to RTX reduced the pain,  but pretreat-
ment with 2ｵ lidocaine was much less eﬀective [2,  
6].  Brown et al.  [3] administered general anesthesia 
to dogs with bone cancer up to 60min before adminis-
tering intrathecal RTX to inhibit the initial hyperal-
gesic response.  However,  neither general anesthesia 
nor the use of bupivacaine to induce a nonselective 
motor and sensory block appears to be a practical 
pretreatment option.
　Intrathecal clonidine was shown to relieve intrader-
mal capsaicin-induced hyperalgesia in human volun-
teers [7],  and Eisenach et al.  [8] demonstrated that 
the potency of epidural clonidine is similar to that of 
intrathecal clonidine in chronic neuropathic pain 
patients,  although the reasons for the similar poten-
cies are unclear.  No pain or agitated behavior associ-
ated with perineural clonidine injection has been 
reported [9].  Moreover,  clonidine has been known to 
be more potent when given neuraxially than when given 
systemically [10].
　 The primary goal of the present study was to 
determine whether an epidural clonidine injection can 
reduce the initial thermal hyperalgesic response to 
RTX.  The secondary goal of the study was to assess 
the eﬀect of clonidine pretreatment on the long-term 
analgesic eﬀect of RTX in a rat model of neuropathic 
pain.
Methods
　 Rat model of neuropathic pain. The experi-
mental procedures were approved by our institutionʼs 
Animal Care Committee.  Male Sprague-Dawley rats 
purchased from Orient Bio (Seongnam,  Korea) were 
housed in clear plastic cages with sawdust bedding at 
room temperature (20-22℃) and humidity (55-60ｵ) 
under a 12-h light/dark cycle.  The animals were 
acclimatized for at least 3 days prior to the study.
　 Seven-wk-old rats weighing 230-250g were anes-
thetized with 2ｵ isoﬂurane/O2 via a loose-ﬁtting 
mask.  The spinal nerve ligation model was created 
with a cutting method [11].  For each animal,  a 3-cm 
paramedian incision was made in the left L4-sacral 
area,  and a bundle of paraspinal muscles was removed 
to visualize the left L6 transverse process.  Using 
small scissors,  we removed the left L6 transverse 
process completely and exposed the L4-L5 spinal 
nerves.  After the L4 spinal nerve was separated,  the 
L5 spinal nerve was cut and spread laterally.  The 
fascia and skin were closed using sutures,  and the 
animals were allowed to recover for 10 days prior to 
the epidural catheterization.
　 Animals that exhibited tactile hypersensitivity to 
von Frey ﬁlaments on the 10th day post-spinal nerve 
ligation were included in the treatment experiments.  
Rats that showed a motor deﬁciency or failed to 
exhibit tactile hypersensitivity were excluded from 
further testing.
　 Epidural catheterization. Rats were anesthe-
tized using the technique described above.  After 
sterile preparation of the skin,  a 3-cm midline incision 
was made at the L1-L2 level.  The superﬁcial fascia 
and muscles were dissected,  and the L1 and L2 
spinous processes were exposed.  Holding the L2 
spinous process using tooth forceps,  we removed the 
L1 spinous process,  and the surrounding muscles 
were carefully separated until the ligamentum ﬂavum 
was exposed.  A small hole was made with a blunted 
26-gauge needle at the center of the ligamentum ﬂa-
vum,  and a PE-10 catheter (Becton Dickinson and 
Company,  Franklin Lakes,  NJ,  USA) was advanced 
approx.  3cm caudally until the tip reached the L4-L5 
interspace [12].  The total tube length was 17cm,  
and the dead space was 12µL.  Polyethylene glue (a 
cyanoacrylate adhesive; Aron Alpha,  Toagosei,  Tokyo,  
Japan) was applied around the catheter entry site to 
prevent drug leakage.  The catheter was tunneled 
subcutaneously near the neck,  and 0.1mL of 2ｵ 
lidocaine was injected as a test dose.  Any rats for 
which an accidental intrathecal or intravenous injec-
tion of test agents led to sudden death were not 
included in the experiment [12].  After the correct 
epidural catheter placement was conﬁrmed,  the fascia 
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and skin were closed with sutures.  If a rat exhibited 
a limp or spinal deformity during the 2-day observa-
tion period,  it was excluded from the study.
　 To conﬁrm that the injected agents reached the 
L4-L5 level,  we administered 20µL of Evans blue 
(Sigma-Aldrich,  St. Louis,  MO,  USA) to 6 rats 
through the epidural catheter and sacriﬁced them by 
transcardial perfusion with 0.1M phosphate buﬀer.  In 
another 6 rats,  20µL of Evans blue was injected 
twice,  20min apart,  and we visually conﬁrmed that 
the injections also reached the L4-L5 epidural level,  
although 2 injections resulted in a wider distribution 
than a single injection.
　 Drugs and epidural administration. RTX 
1mg (Sigma-Aldrich) was dissolved in 95ｵ ethanol 
(1mL) to a concentration of 1µg/µL and stored at 
－20℃.  It was diluted using 0.9ｵ normal saline to 
the required concentration [1,  13].  Clonidine hydro-
chloride (1mg/mL) with no preservatives (lot 807126) 
was obtained from the Duke Compounding Pharmacy 
at Duke University Medical Center (Durham,  NC,  
USA).
　 Thirty-six epidurally catheterized rats (weighing 
280-330g at that point) were prepared for the 
experiment.  We administered the drugs 2 days after 
catheterization [14].  The rats were randomly divided 
into 6 treatment groups (n＝6 each): control (normal 
saline 20µL),  RTX 500ng,  RTX 1µg,  clonidine 
20µg (Cl),  Cl＋RTX 500ng,  and Cl＋RTX 1µg.  The 
injection volume was 20µL for each concentration.
　 Our decision to use a clonidine concentration of 
20µg was based in part on previous studies that 
reported that 20µg was an optimal analgesic eﬀect for 
intrathecal clonidine [15,  16].  In our preliminary 
study with the spinal nerve ligation model,  rats were 
given either 20µg or 40µg clonidine epidurally (6 rats 
per group).  The animals in the latter group were so 
sedated that they could not stand for about 30min 
afterward,  and the thermal thresholds were not supe-
rior to those for the clonidine 20µg group (data not 
shown).  For these reasons,  we chose the clonidine 
concentration of 20µg for our study.
　 We chose the RTX concentrations of 500ng and 
1µg based on the results we obtained in our previous 
study [5] in which transient initial hyperalgesia and 
signiﬁcant sedation were observed at doses ｧ2µg,  
whereas only initial thermal hyperalgesic responses 
were elicited at 500ng and 1µg.  The eﬃcacy of cloni-
dine pretreatment was more prominent with RTX 1µg 
than with RTX 500ng.
　 The choice of a 20-min interval between the cloni-
dine administration and RTX administration was based 
on our preliminary clonidine study.  Following the 
epidural administration of clonidine 20µg,  the onset of 
analgesia in response to mechanical stimulation occurred 
slowly over the ﬁrst 60min,  whereas the onset of 
analgesia in response to thermal stimulation occurred 
within the ﬁrst 15min.  Hence,  we felt that a 20-min 
interval would be suﬃcient to inhibit the initial RTX-
associated hyperalgesic response to thermal stimula-
tion.
　 After anesthetizing the rat with 2ｵ isoﬂurane/O2,  
we injected RTX or clonidine for 15-20sec via an 
epidural catheter using a microinjector syringe 
(Hamilton Co. Reno,  NV,  USA).  For the rats that 
received both clonidine and RTX,  clonidine was 
injected ﬁrst and RTX was injected 20min later.
　 Behavioral tests. Mechanical stimulation and 
the thermal test were performed by the same researcher,  
who was blinded to the drugs injected.  The ratsʼ 
responses to a graded mechanical stimulus with von 
Frey ﬁlaments (Stoelting,  Wood Dale,  IL,  USA) 
were measured.  Each rat was placed under a trans-
parent plastic dome on a metal mesh ﬂoor for 20min.  
A von Frey ﬁlament was applied to the mid-plantar 
surface of the left hind paw for 2-3sec.  The 50ｵ 
withdrawal threshold was determined using the up-
down method [17] starting with a 2.0g (19.608mN) 
ﬁlament.  A rapid foot lift upon ﬁlament contact was 
regarded as a withdrawal response.  Interpolation of 
the 50ｵ threshold was carried out according to the 
Dixon method [18].
　 To assess thermal pain sensitivity,  we used a 
modiﬁed Hargreaves test [19] with a plantar test 
device (7,371; Ugo Basile,  Comerio,  Italy).  Each rat 
was allowed to move freely for 20min on a glass ﬂoor 
within an open-top transparent plastic box.  The sur-
face of the glass was maintained at 28-30℃ using a 
heating pad and an electric stove [11].  A mobile radi-
ant heat source (infrared radiant intensity: 60) was 
applied through the glass platform to the plantar sur-
face of the ratʼs left hind paw [20].  To prevent ther-
mal injury,  the exposure cutoﬀ time was 15sec [20].  
No visible tissue damage was observed under these 
conditions.  The average of 3 consecutive measure-
ments was documented.
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　 Behavioral tests were performed immediately 
before the spinal nerve ligation and before the initial 
epidural drug administration of clonidine or RTX,  and 
subsequently at 15-min intervals for 180min and then 
at 1,  3,  5,  7,  10,  15,  and 20 days.  At the same 
time,  we observed the sedation status and behaviors 
of the rats of all groups.  The same researcher who 
performed the mechanical and thermal tests examined 
the ratsʼ behaviors,  and he was blinded to the drugs 
injected.  We did this experiment using rats that were 
reared by hand,  and we always petted the rats for 
about 10min before starting the experiment.  After 
one researcher administered RTX to the rats,  the 
other researcher observed the ratsʼ behaviors continu-
ously and recorded them.  The sedative appearance of 
the rats were recorded according to Kawamataʼs seda-
tion score [21].
　 Statistical analysis. The statistical analyses 
were performed using SigmaPlot for Windows version 
12.0 (2011; Systat Software,  San Jose,  CA,  USA).  
We used the Kruskal-Wallis one-way analysis of vari-
ance (ANOVA) by ranks to compare the responses to 
mechanical and thermal stimuli among the 6 treatment 
groups.  For multiple comparisons after each analysis,  
the Tukey test was used.  The data are expressed as 
means with standard deviations.  P-values ＜0.001 
were considered signiﬁcant.  The signiﬁcance of diﬀer-
ences in the ratsʼ responses to mechanical and thermal 
stimuli was determined for comparisons between the 
control group and other groups and between the RTX-
only and Cl-RTX groups.
Results
　 Short-term responses to mechanical and ther-
mal stimulation. The thresholds for the post-
RTX withdrawal of the left hind paw in response to 
mechanical stimuli for the initial 180min are shown in 
Fig.  1A.  The Cl group threshold gradually increased 
for the ﬁrst 60min and remained steady thereafter,  
and was signiﬁcantly higher than the corresponding 
thresholds for the control group (p＜0.001).  The 
RTX 1µg,  Cl＋RTX 500ng,  and Cl＋RTX 1µg groups 
showed almost immediate increases in the withdrawal 
threshold,  which were maintained for 180min; the 
results for these treatment groups were,  for the most 
part,  signiﬁcantly higher than the results for the 
control group (p＜0.001) as well as the RTX 500ng 
group (p＜0.001).  There were no signiﬁcant diﬀer-
ences among the RTX 1µg,  Cl＋RTX 500ng,  and 
Cl＋RTX 1µg groups.  The increased withdrawal 
threshold for the RTX 500ng group was not signiﬁ-
cantly diﬀerent from the withdrawal threshold for the 
control group.  The latencies of the ratsʼ withdrawal 
from the thermal stimuli for the initial 180min are 
shown in Fig.  1B.  The Cl group showed a signiﬁcant 
increase in withdrawal latency compared to the control 
group during the ﬁrst 15min after the injection (p＜
0.001),  with the increased withdrawal latency remain-
ing steady throughout the 180min.  For the RTX 
500ng and RTX 1µg groups,  the initial latency was 
numerically lower than that of the control group dur-
ing the ﬁrst 60min,  even though there were no sig-
niﬁcant diﬀerences compared to the control group.  
Thereafter,  the latency of the RTX 1µg group 
increased substantially and plateaued,  whereas the 
latency of the RTX 500ng group increased at a much 
slower rate.  We thus named the ﬁrst 60-min.  period 
after the ʻpostʼ state the hyperalgesic period and the 
time after this 60-min.  period the analgesic period.
　Among the RTX-treated rats (at all RTX concen-
trations),  the withdrawal latency increased much more 
rapidly in the rats that were pretreated with clonidine 
than in those that were not pretreated.  The with-
drawal latency did not diﬀer signiﬁcantly between the 
RTX 1µg and Cl＋RTX 1µg groups except for the 
ﬁrst 60min.
　 We observed and summarized the degree of seda-
tion and behavior pattern of the rats in all groups in 
Table 1.  The rats of the Cl group sat quietly,  some-
times standing or grooming but with no spontaneous 
movement; for 30min they moved when touched before 
returning to the pre-drug state over time.  The rats in 
the RTX 500ng and Cl＋RTX 500ng groups exhibited 
no abnormal behaviors.  There were diﬀerences in 
behavior between the RTX 1µg group and the 
Cl＋RTX 1µg group.  Of the 6 rats in the RTX 1µg 
group,  4 were aroused spasmodically and presented 
with very irritable behavior such as shoveling their 
feces; 5 scratched the metal mesh ﬂoor nervously,  
and 2 vocalized when the examiner touched them.  
Such behaviors persisted for up to 60-90min.  In 
contrast,  the rats in the Cl＋RTX 1µg group did not 
exhibit irritable behaviors and remained calm and 
comfortable.  The sedation status gradually went back 
to the initial state over time,  and there were no motor 
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impairments or autotomic appearances in any of the 
groups.  The rats in all groups did not show any seda-
tion or abnormal behaviors from days 1 to 20.
　 Long-term responses to mechanical and ther-
mal stimulation. The post-RTX withdrawal 
thresholds of the left hind paw in response to mechan-
ical stimuli over 20 days are shown in Fig.  2A.  In the 
Cl＋RTX 500ng and Cl＋RTX 1µg groups,  the with-
drawal thresholds were initially substantially higher 
than in the corresponding groups without clonidine 
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Fig. 1　 Time course of the ratsʼ left hind paw withdrawal threshold (A) and latency (B) in response to mechanical and thermal stimula-
tion during the ﬁrst 180min after an epidural administration of clonidine (Cl),  resiniferatoxin (RTX),  or both.  Rats were treated epidurally 
with normal saline (control group) (●),  RTX 500ng (○),  RTX 1µg (▼),  clonidine 20µg (Cl) (△),  Cl＋RTX 500ng (■),  or Cl＋RTX 1µg 
(□).  (A) The withdrawal thresholds,  determined at 15-min intervals,  increased signiﬁcantly in the Cl,  RTX 1 µg, Cl＋RTX 500ng, and Cl
＋RTX 1µg groups.  (B) During the ﬁrst 60min,  the RTX 500ng and RTX 1µg groups had an initial hyperalgesic response; rats that were 
pretreated with clonidine before receiving those doses of RTX did not have an hyperalgesic response.  ＊P＜0.001 vs. the control group,  
†P＜0.001 vs. the RTX 500ng group,  ‡P＜0.001 vs. the RTX 1µg group.  All data are means ± SD (6 rats per group).  Pre,  before the 
spinal nerve ligation; Post,  before the epidural drug injection.
pretreatment.  In the Cl＋RTX 1µg group,  the threshold 
was signiﬁcantly higher than that in the control group 
at days 1 and 3 (p＜0.001),  whereas the threshold 
diﬀerence in the Cl＋RTX 500ng group was signiﬁ-
cantly higher than in the RTX 500ng group at day 3 
(p＜0.001).  The withdrawal threshold for each group 
returned to the baseline by post-drug day 10.  The Cl 
only group failed to show a sustained analgesic eﬀect 
in response to mechanical stimulation,  even though the 
withdrawal threshold had increased compared to the 
pre-drug injection level during the initial 180min after 
the drug administration.
　 In the long-term study (Fig.  2B),  the withdrawal 
latency in the Cl＋RTX 1µg group was signiﬁcantly 
higher than that in the control group throughout the 
entire 20 days of observation,  whereas the with-
drawal latency in the RTX 1µg group remained higher 
for 10 days; there were no signiﬁcant diﬀerences 
between the RTX 1µg and Cl＋RTX 1µg groups.  In 
the RTX 500ng and Cl＋RTX 500ng groups,  the 
withdrawal latency was signiﬁcantly increased for 3 
days post-drug injection compared to the pre-drug 
injection,  and it decreased thereafter to the pre-drug 
injection level.  The Cl-alone group did not show a 
sustained analgesic eﬀect in response to thermal 
stimulation,  even though the withdrawal latency was 
increased for the initial 180min after drug adminis-
tration.
Discussion
　 The results of this study demonstrated that pre-
treatment with clonidine mitigated the initial thermal 
hyperalgesic response to RTX in a rat model of neu-
ropathic pain.  TRPV1 receptors play an important 
role in the development of allodynia and hyperalgesia 
following injury and the ensuing inﬂammatory condi-
tions.  RTX has an analgesic eﬀect via TRPV1 binding 
and desensitizes only sensory neurons [1-3].
　 Sensory nerve endings release a variety of proin-
ﬂammatory neuropeptides in neuroinﬂammation,  such 
as calcitonin gene-related peptide,  substance P,  gala-
nin,  cholecystokinin,  and somatostatin [4].  RTX has 
been demonstrated to reduce neuropathic pain by up-
regulating galanin message-associated protein,  vasoac-
tive intestinal polypeptide,  neuropeptide Y,  or nitric 
oxide synthase or by depleting calcitonin gene-related 
peptide or substance P from the aﬀected neurons [4,  
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Table 1　 The sedative and agitated behaviors of the rats
Group Agitated behavior Sedation scorea
Control Normal behaviors (6/6) 0 (6/6)b
Clonidine 20µg (Cl) Quiet and comfortable appearance 1 or 2 for approx.  30min
RTX 500ng Normal behaviors,  but an irritable appearance with 
touch
0 (6/6)
RTX 1µg Shoveling feces (4/6),  scratching the metal mesh 
ﬂoor nervously (5/6),  vocalization (2/6) for 60-90min
Dozing oﬀ brieﬂy and aroused spasmodically with 
very irritable behaviors (6/6)c
Cl＋RTX 500ng Normal behaviors,  no irritable appearance 1 or 2 for approx.  30min
Cl＋RTX 1µg Normal behaviors,  no irritable appearance,  very calm 
and comfortable
1 or 2 for 60-90min
aIntensity of sedation using a modiﬁcation of the scale proposed by Kawamata et al. [21].
0: normal behavior,  alert to the environment,  standing or grooming
1: sitting quietly,  sometimes standing or grooming
2: sitting quietly,  no spontaneous movement,  but moved when touched
3: no spontaneous movement,  moved when touched but ﬂattened itself within several seconds
4: no spontaneous movement,  did not move when touched
5: loss of righting reﬂex,  unresponsive
bThe number of animals that showed the occurrence out of the 6 rats in the group.
cThe rats of the RTX 1µg group also showed a sedative appearance,  but all were startled again and again with simultaneous agitated 
behaviors compared to the rats of the clonidine group,  so we did not apply the same sedative score rule in the RTX 1µg group.
22-24].
　 RTX produces an initial depolarization of primary 
sensory neurons,  including TRPV1 receptors,  causing 
pungency and irritation,  followed by long-lasting 
desensitization of the nerve [1-3,  6].  Previous stud-
ies attributed the hyperalgesia initially induced by 
RTX to calcium accumulation within neurons,  which 
in turn causes calcium cytotoxicity [3,  25].  Bupivacaine 
has been injected prophylactically in attempts to miti-
gate the initial excitatory responses to RTX,  with 
limited success [2,  6].  Conduction blocks with local 
anesthetics have produced only short-term analgesia 
with nonselective motor or sensory dysfunction [2,  6].
　 An epidural RTX-induced thermal hyperalgesic 
response was shown to precede the analgesic eﬀect [1,  
5].  In the present study,  even though the decrease in 
thermal latencies in the RTX-treated groups was not 
signiﬁcant compared to the control group during the 
hyperalgesic period (ﬁrst 60min.  after the post-state),  
dose-dependent eﬀects of RTX were clearly shown 
during the analgesic period.  We suspect that RTX-
induced hyperalgesia might be buried in the already 
established thermal hyperalgesia of the neuropathic 
pain rat model,  and this idea is consistent with the 
results of our precious study [5].
　 The unique properties of clonidine are well known.  
Intrathecal clonidine results in thermal and mechanical 
antinociception in a rat model of neuropathic pain 
[15,  21] and has an additive analgesic eﬀect with 
local anesthetics and opioids [10].  Eisenach et al.  [8] 
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Fig. 2　 Time course of the ratsʼ left hind paw withdrawal threshold (A) and latency (B) in response to mechanical and thermal stimula-
tion during the ﬁrst 20 days after the epidural administration of clonidine,  RTX,  or both.  Rats were treated epidurally with normal saline 
(control group) (●),  RTX 500ng (○),  RTX 1µg (▼),  clonidine 20µg (Cl) (△),  Cl＋RTX 500ng (■),  or Cl＋RTX 1µg (□).  (A) The 
withdrawal thresholds increased signiﬁcantly more in the clonidine-RTX groups than in the RTX-only groups,  and the increased withdrawal 
threshold in the Cl＋RTX 1µg group was sustained for 3 days.  (B) The withdrawal latency remained increased in the Cl＋RTX 1µg group 
for 20 days.  ＊P＜0.001 vs. the control group,  †P＜0.001 vs. the RTX 500ng group.  All data are means ± SD (6 rats per group).  Pre,  
before the spinal nerve ligation; Post,  before the epidural drug injection.
reported that epidural or intrathecal clonidine allevi-
ated intradermal capsaicin-induced allodynia in healthy 
volunteers.  α2-Adrenoceptor agonists such as clonidine 
increase the potency and eﬃcacy of analgesia by con-
comitantly changing excitatory and inhibitory recep-
tors in aﬀerent neurons following peripheral nerve 
injury [10,  26].
　 In the present study,  pretreatment with clonidine 
eliminated the early hyperalgesic response to RTX 
while improving the beneﬁt of RTX by further 
increasing the withdrawal threshold to mechanical 
stimulation and sustaining the duration of the increased 
thermal withdrawal latency during short-term 
responses (180-min,  Fig.  1A,  B).  Our ﬁndings con-
ﬁrmed the previous reports that the eﬀect of clonidine 
is more prominent in the neuropathic pain state than 
under non-neuropathic conditions [7,  8,  10,  26-28].  
When we observed the long-term analgesic eﬀect of 
clonidine on RTX,  the mechanical analgesic eﬀect was 
very short (less than 3 days),  and the diﬀerence in the 
thermal analgesic eﬀect was not signiﬁcant between 
the RTX group and clonidine-RTX group (Fig.  2).  We 
were thus unable to observe the additive or potenti-
ated eﬀect of clonidine on RTX,  which is a limitation 
of this study.
　 In contrast to our present ﬁndings,  Chen et al.  
[16] observed that clonidine signiﬁcantly potentiated 
the eﬀect of intrathecal RTX,  possibly due to reduced 
desensitization of α2-adrenoceptors in the spinal cord.  
Ma et al.  [26] reported that TRPV1 and α2C- 
adrenoceptors,  and their co-expression were up-regu-
lated in injured dorsal root ganglion cell bodies after 
nerve ligation,  and that the proportion of clonidine-
inhibited cells that responded to capsaicin was 
increased by ﬁvefold after nerve injury.  Our study 
lacked detailed histological ﬁndings,  and thus addi-
tional studies including immunostaining for TRPV1 
receptor and α2-adrenoreceptor are necessary to fur-
ther investigate the potentiation of RTX eﬀects by 
clonidine and to analyze any neurotoxic eﬀects of clo-
nidine-RTX combinations [29].
　 Clonidine-induced sedation is attributed to cloni-
dineʼs rapid systemic absorption and redistribution to 
the central nervous system in a dose-dependent manner 
irrespective of the route of administration [7,  10].  
Whether the rapid onset of the α2-agonist-related 
analgesic property can be distinguished from the seda-
tive eﬀect is not clear,  but it is known that clonidine 
eliminates the initial hyperalgesic response to RTX.  
In a typical clinical scenario,  clonidine alone does not 
induce profound respiratory depression,  and the level 
of sedation has been shown to be dose-dependent [10,  
30].  Rauck et al.  [27] reported similar degrees of 
systemic absorption and central distribution after 
cervical,  thoracic,  and lumbar epidural injections of 
clonidine,  with minimal dispersion along the neuraxis.
　 Because the systemic absorption of clonidine after 
spinal administration is rapid,  the onset of side eﬀects 
from epidural clonidine occurs early [10,  28].  With 
the limited clonidine dose of 20µg,  we did not observe 
any signiﬁcant side eﬀects,  abnormal behaviors,  or 
deaths during the study period.  We did not examine 
the potential side eﬀects of hypotension,  bradycardia,  
or respiratory diﬃculty.
　 In conclusion,  RTX provided signiﬁcant initial 
transient hyperalgesia followed by a prolonged analge-
sic eﬀect in response to a thermal stimulus in a rat 
model of neuropathic pain.  Although we cannot pre-
cisely conﬁrm that pretreatment with clonidine poten-
tiates or adds to the analgesic eﬀect of RTX,  we 
found that clonidine pretreatment with epidural RTX 
eliminated the initial RTX-associated hyperalgesic 
response and systemic toxicity in the neuropathic pain 
rat model used here.  This ﬁnding contributes to the 
potential clinical uses of RTX in the future.
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